Filing Details

Accession Number:
0001127602-15-013283
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-01 20:35:17
Reporting Period:
2015-03-30
Filing Date:
2015-04-01
Accepted Time:
2015-04-01 20:35:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
920148 Laboratory Corp Of America Holdings LH Services-Medical Laboratories (8071) 133757370
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1457713 E Mark Brecher 531 South Spring Street
Burlington NC 27215
Cmo, Labcorp Diagnostics No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-30 519 $0.00 7,108 No 4 A Direct
Common Stock Disposition 2015-03-30 172 $127.28 6,936 No 4 F Direct
Common Stock Acquisiton 2015-03-30 11,600 $90.74 18,536 No 4 M Direct
Common Stock Acquisiton 2015-03-30 7,600 $84.86 26,136 No 4 M Direct
Common Stock Disposition 2015-03-30 20,278 $126.98 5,858 No 4 S Direct
Common Stock Disposition 2015-03-31 347 $127.00 5,511 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 F Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock Options Disposition 2015-03-30 11,600 $0.00 11,600 $90.74
Common Stock Non-qualified Stock Options Disposition 2015-03-30 7,600 $0.00 7,600 $84.86
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2012-02-09 2021-02-09 No 4 M Direct
3,800 2013-05-24 2022-05-23 No 4 M Direct
Footnotes
  1. Shares acquired on March 28, 2015, pursuant to a performance award granted on February 28, 2012, relating to performance during the three-year period ended December 31, 2014.
  2. Stock withholding to satisfy tax withholding obligations.
  3. Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
  4. The price of $126.9815 per share represents a weighted average of sale prices ranging from $126.49 to $127.22 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  5. Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
  6. The option vested in three equal annual installments beginning on the date reflected in this column.
  7. Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2012 Omnibus Incentive Plan.
  8. The option vests in three equal annual installments beginning on the date reflected in this column.